Home › Funds › Geode Capital Management › PTGX
Geode Capital Management position in PTGX
PROTAGONIST THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.74M sh
Reported value held$213.48M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 728.93K | $12.92M | New |
| Q4 2021 | 778.08K | $26.61M | Add |
| Q1 2022 | 832.92K | $19.72M | Add |
| Q2 2022 | 821.92K | $6.50M | Reduce |
| Q3 2022 | 827.46K | $6.97M | Add |
| Q4 2022 | 879.89K | $9.60K | Add |
| Q1 2023 | 925.99K | $21.30M | Add |
| Q2 2023 | 1.08M | $29.75M | Add |
| Q3 2023 | 1.18M | $19.71M | Add |
| Q4 2023 | 1.25M | $28.63M | Add |
| Q1 2024 | 1.29M | $37.43M | Add |
| Q2 2024 | 1.37M | $47.52M | Add |
| Q3 2024 | 1.37M | $61.87M | Hold |
| Q4 2024 | 1.38M | $53.17M | Hold |
| Q1 2025 | 1.42M | $68.86M | Add |
| Q2 2025 | 1.44M | $79.83M | Add |
| Q3 2025 | 1.42M | $94.12M | Reduce |
| Q4 2025 | 1.45M | $126.92M | Add |
| Q1 2026 | 1.67M | $175.98M | Add |
| Q2 2026 | 1.74M | $213.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PTGX
- BlackRock Inc 10.31M sh · $1.26B · Q2 2026
- Farallon Capital Management 6.35M sh · $778.25M · Q2 2026
- Vanguard Group 5.41M sh · $472.83M · Q4 2025
- Wellington Management Group 3.42M sh · $418.83M · Q2 2026
- UBS Group AG 3.40M sh · $416.68M · Q2 2026
- Janus Henderson Group 2.89M sh · $304.87M · Q1 2026
- Invesco Ltd 2.34M sh · $286.92M · Q2 2026
- Bank of America Corp 1.32M sh · $162.36M · Q2 2026
- Morgan Stanley 905.99K sh · $111.06M · Q2 2026
- Goldman Sachs Group 812.85K sh · $99.64M · Q2 2026
- Fidelity Management & Research (FMR) 672.19K sh · $82.40M · Q2 2026